Kamaran Ahmed Mohammed a and Hawar Hasan Ali Ghalib b

a Radiotherapy Board Student, KBMS.  

b Department of Surgery, College of Medicine, University of Sulaimani. 

Submitted: 29/7/2018; Accepted: 27/3/2018; Published 21/1/2019

DOI Link: https://doi.org/10.17656/jsmc.10190 



Colorectal cancer (CRC) is one of the leading causes of mortality and morbidity in the world. It is the third most common malignancy and the fourth leading cause of cancer-related deaths worldwide, accounting for approximately 1,400,000 new cases and about 700,000 deaths worldwide.


The objective of this study is to assess patients’ response and developments of complication, after the use of neo-adjuvant short course radiotherapy in addition to the effect of this treatment modality on pathological response, local control and distant metastasis.


Forty six patients, who were histopathologically proven to have colorectal carcinoma, were randomly assigned to receive 25 Gy of radiation, in a short period of time prior to surgical resection of tumor. Local control, distance metastasis and post operative signs and symptoms measured over a period of 5 years (2013-2018). The treatment period ranged between 3-327 days.


The overall survival of patients and their experience with post operative toxicity was improved; there was statistically significant correlation between spread of the tumor and duration of radiotherapy, p value was less than 0.05.In addition 84% of cases had no recurrence. Overall survival was about 76% of cases at the end of this research. The rate of post operative complication decreased. But the duration of radiotherapy had no significant effect on the mortality. (p value=0.2) 


Preoperative short-course radiotherapy before colorectal surgical intervention favors better local control and distant metastasis in addition to less complication, more comfort for patients and favorable survival rate. 


Neo-adjuvant Short Course Radiotherapy, Rectal Cancer. 


1-.Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi RE, Corcione F. Worldwide burden of colorectal cancer: a review. Updates in surgery. 2016 Mar 1;68(1):7-11.

2 - Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2016 Jan 5:gutjnl-2

3-Abid M, Mansouri MA, Bataiche A, Ballah Y, Brahimi M. Benefits of Neoadjuvant Hypofractionated Radiotherapy in the Treatment of Locally Advanced Adenocarcinomas. J Gen Pract (Los Angel). 2017;5(315):2.

4- Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA: a cancer journal for clinicians. 2009 Nov 1;59(6):366-78.

5-Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New England Journal of Medicine. 2004 Oct 21;351(17):1731-40.

6- Gunderson LL . Clinical radiation oncology. Elsevier Health Sciences; 2015 Aug 12.

7-Frykholm GJ, Glimelius B, Påhlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Diseases of the colon & rectum. 1993 Jun 1;36(6):564-72.

8-Cammà C, Giunta M, Fiorica F, Pagliaro L, Craxì A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. Jama. 2000 Aug 23;284(8):1008-15.

9- Bujko K, Nowacki MP, Nasierowska Guttmejer A, Michalski W, Bebenek M, Kryj M. Long‐term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. British Journal of Surgery. 2006 Oct 1;93(10):1215-23.

10-Skóra T, Nowak-Sadzikowska J, Martynów D, Wszołek M, Sas-Korczyńska B. Preoperative short-course radiotherapy in rectal cancer patients: results and prognostic factors. Journal of radiation oncology. 2018 Mar 1;7(1):77-84

11-Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012 Jun 1;30(16):1926-33.

12. Musio D. Neoadjuvant-intensified treatment for rectal cancer: Time to change? World Journal of Gastroenterology. 2013;19(20):3052.

13-Skóra T, Nowak-Sadzikowska J, Martynów D, Wszołek M, Sas-Korczyńska B. Preoperative short-course radiotherapy in rectal cancer patients: results and prognostic factors. Journal of radiation oncology. 2018 Mar 1;7(1):77-84.

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.